Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 840 results for "novartis ag"

FDA Okays Novartis AG's (NVS) Signifor LAR To Treat Acromegaly
Bidness Etc

FDA Okays Novartis AG's (NVS) Signifor LAR To Treat Acromegaly

Novartis AG (ADR) ( NYSE:NVS ) announced Tuesday that its drug Signifor LAR has been approved by the US Food and Drug Administration (FDA) to treat acromegaly in patients on whom prior treatments have not worked or for whom surgery is not an option. Bidness Etc, 23 hours ago
[x]  

32 images for novartis ag

Haaretz, 1 day ago
Bidness Etc, 23 hours ago
Money Today, 6 hours ago
Bidness Etc, 2 weeks ago
Bidness Etc, 2 weeks ago
Bidness Etc, 2 weeks ago
Reuters UK, 2 weeks ago
4 Traders, 2 weeks ago
Yahoo! News, 3 weeks ago
Press TV, 1 week ago
Business Today India

Novartis sues Cipla over drug patent, HC reserves verdict

Novartis AG, the Swiss drug manufacturer, said on Wednesday it had sued Cipla for infringing patents covering its respiratory drug Onbrez, a month after the home-grown drugmaker launched a copy at a fifth of the original drug's price. Cipla, the ...
 Business Today India20 hours ago Novartis sues India's Cipla over respiratory drug Onbrez  CNBC22 hours ago Cipla, Sony Hack, Nestle, Fogerty: Intellectual Property  Bloomberg2 days ago Novartis sues Cipla over respiratory drug Onbrez  Reuters7 hours ago
[x]  
Livemint.com

Cipla V/s Novartis

The Delhi high court has reserved its verdict on a dispute between pharma firms Novartis AG and Cipla Ltd over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease. According to the report, the Delhi high court ...
 India Infoline7 hours ago Delhi HC reserves order on Novartis-Cipla drug dispute  Livemint.com18 hours ago

Novartis sues Cipla for infringing patents

Comment · print · T T T+· T- TOPICS Swiss drugmaker Novartis AG said on Wednesday it had sued Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's ...
 The Hindu21 hours ago
Malta Independent Daily

European drug regulator: Novartis flu vaccine OK

Europe's drug regulator says there is no proof that a flu vaccine for the elderly was linked to side effects, including deaths in Italy. Last week, Italy pulled two batches of Fluad, made by Switzerland's Novartis AG, after reports that people died ...
 Malta Independent Daily19 hours ago
Reuters India

Novartis buys 12.8% stake in BioLineRX

Swiss drugmaker Novartis AG bought a 12.8 per cent stake in Israeli biopharmaceutical company BioLineRX Ltd as part of a multi-year collaboration deal, BioLineRX said on Tuesday.Under the agreement, Novartis, which invested an initial $10 million, ...
 Business Standard1 day ago Novartis buys 12.8 per cent stake in BioLineRX in co-development deal  Economic Times1 day ago Novartis buys 12.8 percent stake in BioLineRX in co-development deal  Reuters India1 day ago Novartis buys 12.8 pct stake in BioLineRX in co-development deal  Reuters1 day ago
[x]  
Business Standard

Cipla asks govt to revoke Novartis patents on respiratory drug

Generic drugmaker Cipla Ltd said on Thursday it had requested the government to revoke five patents held by Swiss firm Novartis AG on respiratory drug Onbrez, to boost its access in the Indian market. Cipla alleged that Novartis has had patents on the drug ...
 Business Standard1 month ago Cipla asks India to revoke Novartis patents on respiratory drug  Business Standard1 month ago

FACTORS MOVING MARKETS : Analyst Coverage on Boeing, Crocs, PetSmart, Novartis and IDT

/PRNewswire/ -- Moments ago, Realtime Equities released new analyst updates concerning several important developing situations. Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA(R) ...
 4 Traders1 day ago Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis  TickerTech.com2 days ago Factors Moving Markets: Analyst Coverage on Boeing, Crocs, PetSmart, Novartis and IDT  ADVFN India1 day ago Where Investors Are Going - Consensus Report on AngloGold Ashanti, Staples, Delta Air Lines, Novartis and Walgreens  Market Pulse Navigator5 days ago
[x]  

NOVARTIS : Gets U.S. Approval for Hormonal Disorder Drug

By Neil Maclucas ZURICH--Novartis AG (NVS) said Tuesday its Signifor injectable drug has received U.S. regulatory approval for treating patients with a life-threatening hormonal disorder. Basel-based Novartis said the U.S. Food and Drug ...
 4 Traders2 days ago Novartis Gets U.S. Approval for Hormonal Disorder Drug  ADVFN India2 days ago

Novartis: Afinitor Fails to Make a Significant Treatment Difference

By Andrew Morse Novartis AG (NOVN.VX) said on Friday its Afinitor drug failed to make a significant difference in disease-free survival of patients with a type of advanced breast cancer that affects about a fifth of women diagnosed with the ...
 4 Traders5 days ago NOVARTIS : Afinitor Fails to Make a Significant Treatment Difference  4 Traders5 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less